Inventor · disambiguated record
Marc Barry Brown
Also filed as: BROWN MARC · BROWN MARC A · BROWN MARC B · BROWN MARC BARRY
37 granted patents·19 pending applications·154 citations·filing 1997–2025
97Inventor score
Files withACLARIS THERAPEUTICS INC8PALVELLA THERAPEUTICS INC8LEO LABORATORIES LTD6LEO LAB LTD5MEDPHARM LTD3
Top patents by PatentIndex Score
56 records- 0191US11000513B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2019·Granted May 11, 2021·4 cites·22 claims
- 0291US8735375B2Therapeutic compositionsLEO LAB LTD·Filed 2013·Granted May 27, 2014·11 cites·26 claims
- 0391US8377919B2Therapeutic compositionsLEO LAB LTD·Filed 2012·Granted Feb 19, 2013·12 cites·24 claims
- 0490US11135204B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2020·Granted Oct 5, 2021·2 cites·11 claims
- 0590US10729720B2Peroxide formulations and methods and applicators for using the sameACLARIS THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·1 cites·36 claims
- 0690US8716271B2Therapeutic compositionsLEO LAB LTD·Filed 2013·Granted May 6, 2014·9 cites·26 claims
- 0790US8536163B2Therapeutic compositionsLEO LAB LTD·Filed 2013·Granted Sep 17, 2013·9 cites·20 claims
- 0890US8372828B2Therapeutic compositionsLEO LAB LTD·Filed 2012·Granted Feb 12, 2013·10 cites·16 claims
- 0989US10098910B2Peroxide formulations and methods and applicators for using the sameACLARIS THERAPEUTICS INC·Filed 2016·Granted Oct 16, 2018·6 cites·18 claims
- 1089US8207187B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsBECK PETRA HELGA·Filed 2006·Granted Jun 26, 2012·20 cites·16 claims
- 1188US12268673B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2021·Granted Apr 8, 2025·1 cites·11 claims
- 1288US9980983B2Peroxide formulations and methods and applicators for using the sameACLARIS THERAPEUTICS INC·Filed 2017·Granted May 29, 2018·5 cites·25 claims
- 1387US11679101B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2021·Granted Jun 20, 2023·1 cites·52 claims
- 1487US10493071B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsHELPERBY THERAPEUTICS LTD·Filed 2017·Granted Dec 3, 2019·7 cites·2 claims
- 1587US9675639B2Peroxide formulations and methods and applicators for using the sameACLARIS THERAPEUTICS INC·Filed 2015·Granted Jun 13, 2017·5 cites·70 claims
- 1687US8372827B2Therapeutic compositionsLEO LAB LIMTED·Filed 2012·Granted Feb 12, 2013·9 cites·16 claims
- 1787US8278292B2Therapeutic compositionsBROWN MARC BARRY·Filed 2006·Granted Oct 2, 2012·10 cites·18 claims
- 1886US9694006B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsBECK PETRA HELGA·Filed 2012·Granted Jul 4, 2017·12 cites·9 claims
- 1983US10695344B2Topical formulations for delivery of hedgehog inhibitor compounds and use thereofPELLEPHARM INC·Filed 2019·Granted Jun 30, 2020·2 cites·20 claims
- 2083US2024398766A1ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2182US12329748B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2023·Granted Jun 17, 2025·0 cites·51 claims
- 2282US10722499B2Anyhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·1 cites·29 claims
- 2379US12419896B2Compositions and dosage forms for oral deliveryRHODES TECH·Filed 2024·Granted Sep 23, 2025·0 cites·19 claims
- 2478US10493103B2Peroxide formulations and methods and applicators for using the sameACLARIS THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·1 cites·21 claims
- 2578US10369147B2Topical formulations for delivery of hedgehog inhibitor compounds and use thereofPELLEPHARM INC·Filed 2016·Granted Aug 6, 2019·3 cites·10 claims
- 2674US2025213537A1ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2773US8349297B2Topical formulationsMEDPHARM LTD·Filed 2006·Granted Jan 8, 2013·6 cites·33 claims
- 2870US2021137974A1Peroxide formulations and methods and applicators for using the sameACLARIS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2968US10933018B2Isotretinoin formulations and uses and methods thereofTIMBER PHARMACEUTICALS LLC·Filed 2016·Granted Mar 2, 2021·1 cites·12 claims
- 3068US9833428B2Therapeutic compositionsLEO LABORATORIES LTD·Filed 2014·Granted Dec 5, 2017·0 cites·31 claims
- 3167US12011430B2Compositions and dosage forms for oral deliveryRHODES TECH·Filed 2019·Granted Jun 18, 2024·0 cites·14 claims
- 3267US10653721B2Peroxide formulations and methods and applicators for using the sameACLARIS THERAPEUTICS INC·Filed 2017·Granted May 19, 2020·0 cites·27 claims
- 3367US2022362148A1Isotretinoin formulations and uses and methods thereofTIMBER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 3467US2018289654A1Therapeutic CompositionsLEO LABORATORIES LTD·Filed 2017·Application pending·0 cites
- 3565US11413283B2Topical formulations for delivery of hedgehog inhibitor compounds and use thereofPELLEPHARM INC·Filed 2020·Granted Aug 16, 2022·0 cites·21 claims
- 3665US9861603B2Therapeutic compositionsLEO LABORATORIES LTD·Filed 2016·Granted Jan 9, 2018·0 cites·32 claims
- 3765US9833429B2Therapeutic compositionsLEO LABORATORIES LTD·Filed 2016·Granted Dec 5, 2017·0 cites·24 claims
- 3865US9820959B2Therapeutic compositionsLEO LABORATORIES LTD·Filed 2016·Granted Nov 21, 2017·0 cites·31 claims
- 3965US9603822B2Therapeutic compositionsLEO LABORATORIES LTD·Filed 2016·Granted Mar 28, 2017·0 cites·23 claims
- 4063US11471408B2Isotretinoin formulations and uses and methods thereofTIMBER PHARMACEUTICALS LLC·Filed 2020·Granted Oct 18, 2022·0 cites·17 claims
- 4159US2023172937A1Topical formulations of ruxolitinib with an organic amine ph adjusting agent for treatment of skin diseasesINCYTE CORP·Filed 2022·Application pending·0 cites
- 4249US2006130266A1Dermal drug delivery systemBROWN MARC B·Filed 2004·Application pending·0 cites
- 4349US2006140874A1Stable aerosol formulations of peptides and protein with non-cfc propellantsBROWN MARC B·Filed 2003·Application pending·0 cites
- 4448US2020390689A1Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereofDermavant Sciences GmbH·Filed 2019·Application pending·0 cites
- 4548US2013072899A1Pharmaceutical Formulations for Iontophoretic Delivery of GalliumNITRIC BLOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4647US11376213B2Topical pharmaceutical formulationFUTURA MEDICAL DEVELOPMENTS LTD·Filed 2017·Granted Jul 5, 2022·0 cites·19 claims
- 4746US2004058890A1Starch subtypes and lipid metabolismFiled 2003·Application pending·0 cites
- 4845US2010093691A1Topical formulationsHELPERBY THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 4942US2018325839A1Transdermal patchesBUZZZ PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 5041US2015037394A1Drug delivery formulationsWOOD DANIEL GUY·Filed 2012·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Marc Barry Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →